Program Number: 207-000-06-090-H04
Release Date: May 5, 2006
Expiration Date: May 5, 2009
Starting January 1, 2006, pharmacists began to experience a multitude
of new challenges associated with the new Medicare prescription
drug benefit. One of the most time-consuming challenges in the
program will be formulary management. Prior authorization requirements,
step therapy protocols, and tight formularies could become a frustrating
way of life for many community pharmacies and the patients they
serve. It is estimated that most Medicare beneficiaries will encounter
new formulary requirements. Many of these patients, especially
those transitioning from the open formularies of the Medicare
drug discount cards and Medicaid, will need to change their existing
therapy to cover Part D drugs. This transition could be a nightmare
for unprepared pharmacists. During this transition phase, pharmacists
will be in the crucial position of interacting between the plan,
prescriber and patient to lessen any delays in drug coverage.
Preparation will be key for pharmacists to minimize the economic
and humanitarian impact of confused beneficiaries and to limit
any delays in care due to this new program.
Instructions for Participation
To receive a certificate of completion that indicates your eligibility for continuing education credit, you must:
the content of the activity.
- Successfully complete the post-test (70% or higher).
- You will have
two (2) opportunities to successfully complete the activity.
Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.
There is no fee for this activity.
Accreditation expired effective 5/4/2007
Creative Educational Concepts, Inc. is accredited by the Accreditation
Council of Continuing Medical Education (ACCME) to provide continuing
medical education for physicians.
Creative Educational Concepts, Inc. designates this educational
activity for a maximum of 2.0 AMA PRA Category 1 Credit(s).
Physicians should only claim credit commensurate with the extent
of their participation in the activity.
National Community Pharmacists Association (NCPA) is approved by
the Accrediation Council for Pharmacy Education as a provider of
continuing pharmacy education. This program will provide 2.0 contact
hours (.20 CEUs) of continuing pharmacy education credit under the
Accreditation expired effective 5/4/2007
This activity has been approved by the Commission for Case Manager
Certification Approval #7230251886 through 5/4/07 for up to 2.0
clock hours of continuing education credit.
Covington, MS, PharmD (Click
on faculty name to view biography)
Bruno Professor of Pharmacy
McWhorter School of Pharmacy
It is the policy of Creative Educational Concepts, Inc. (CEC) and National Community Pharmacists Association (NCPA) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities.
The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Approval of credit for this continuing education activity does not imply endorsement by CEC and NCPA of any product or manufacturer identified.
Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
Dr. Covington has disclosed that he has no actual or potential
conflcits of interest in relation to this activity.
activity is supported by an educational grant from Boehringer Ingelheim